Furthermore, CLIP4 has been considered a promising epigenetic biomarker by analysis of differentially methylated genes and differentially expressed genes between matched tumor and non-tumor tissues of the colon (Wu et al., 2020). The gene discussed is CLIP4; the disease is neoplasm.